The government shutdown has caused Head Start, a federally funded program designed to help children from low-income households, to run out of money, potentially leaving hundreds of thousands of Black ...
Kygevi (doxecitine and doxribtimine) earned FDA approval as the first treatment for thymidine kinase 2 deficiency, supported by data from a Phase II trial and multiple retrospective studies showing ...